Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on spontaneous movement of human neuroblastoma cells

A new insight into the CaO-induced inhibition pathways on PCDD/F formation: Metal passivation, dechlorination and hydroxide substitution

Ca-based inhibitors (especially CaO) for PCDD/F (polychlorinated dibenzo-p-dioxin and dibenzofuran) formation are considered as economic inhibitors with low toxicity and strong adsorption of acidic gases (e.g., HCl, Cl₂, and SO_x), whereas the insight understanding of its inhibition mechanisms is scarcely explored. Herein, CaO was used to inhibit the de novo reaction for PCDD/F formation (250-450 °C). The evolution of key elements (C, Cl, Cu, and Ca) combined with theoretical calculations was systematically investigated. The concentrations and distribution of PCDD/Fs demonstrated the significant inhibition effect of CaO on I-TEQ (international toxic equivalency) concentrations of PCDD/Fs (inhibition efficiencies: > 90 %) and hepta~octa chlorinated congeners (inhibition efficiencies: 51.5-99.8 %). And the conditions (5-10 % CaO, 350 °C) were supposed to be the preferred conditions applied in real MSWIs (municipal solid waste incinerators). CaO significantly suppressed the chlorination of carbon matrix (superficial organic Cl (CCl) reduced from 16.5 % to 6.5-11.3 %) and the formation of unsaturated hydrocarbons or aromatic carbon (superficial CC decreased from 6.7 % to 1.3-2.1 %). Also, CaO promoted the dechlorination of Cu-based catalysts and Cl solidification (e.g., conversion of CuCl₂ to CuO, and formation of CaCl₂). The dechlorination phenomenon was validated by the dechlorination of highly chlorinated PCDD/F-congeners (via DD/DF chlorination pathways). Density functional theory calculations revealed that CaO facilitated the substitution of Cl by -OH on the benzene ring to inhibit the polycondensation of the chlorobenzene and chlorophenol (Gibbs free energy reduced from +74.83 to -36.62 and - 148.88 kJ/mol), which also indicates the dechlorination effect of CaO on de novo synthesis.

Formation pathways, gas-solid partitioning, and reaction kinetics of PCDD/Fs associated with baghouse filters operated at high temperatures: A case study

The application of the 3T method during combustion (i.e., a Temperature > 850 °C, a residence Time > 2 s, and sufficient Turbulence) can lead to elevated operating temperature in the baghouse filter for the municipal solid waste incineration (MSWI) systems without sufficient heat exchange capacity, which is potentially detrimental to the emission control of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs). Herein, a field study focusing on the distribution and variation of PCDD/Fs in gaseous and solid phases in a baghouse filter with high operating temperature (225-230 °C) was carried out. The concentration of PCDD/Fs in gases at the outlet of the baghouse filter was around 1 order of magnitude higher than that in inlet gases (i.e., noticeable memory effect of PCDD/Fs), because of the significant PCDD/Fs formation in filter fly ash (primarily contributed by the precursor pathway) followed by PCDD/Fs desorption. In addition, the mechanisms and factors resulting in the memory effect of PCDD/Fs were identified based on a laboratory study that carefully investigated the formation and desorption of PCDD/Fs at potential operating temperatures of baghouse filters (i.e., 180, 200, and 225 °C). The temperature was identified as the key factor inducing the memory effect of PCDD/Fs, because: i) PCDD/Fs memory effect was not observed for baghouse filters with low operating temperatures of ~150 °C in previous studies; ii) both the formation and desorption of PCDD/Fs were noticeably favored by rising temperature from 180 to 225 °C; iii) increasing temperature appeared to facilitate the transformation from inorganic Cl to organic Cl and the conversion from aliphatic carbon to aromatic carbon or unsaturated hydrocarbons, both of which were favorable to PCDD/Fs formation; and iv) the release rate of PCDD/Fs from fly ash was exponentially dependent on temperature based on the modeling results of reaction kinetics.

Systematic identification of molecular mechanisms for aryl hydrocarbon receptor mediated neuroblastoma cell migration

Tumor cell migration is affected by the aryl hydrocarbon receptor (AhR). However, the systematic molecular mechanisms underlying AhR-mediated migration of human neuroblastoma cells are not fully understood. To address this issue, we performed an integrative analysis of mRNA and microRNA (miR) expression profiles in human neuroblastoma SK-N-SH cells treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent agonist of AhR. The cell migration was increased in a time- and concentration- dependent manner, and was blocked by AhR antagonist (CH223191). A total of 4,377 genes were differentially expressed after 24-hour-treatment with 10-10 M TCDD, of which the upregulated genes were significantly enriched in cell migration-related biological pathways. Thirty-four upregulated genes, of which 25 were targeted by 78 differentially expressed miRs, in the axon guidance pathway were experimentally confirmed, and the putative dioxin-responsive elements were present in the promoter regions of most genes (79 %) and miRs (82 %) in this pathway. Furthermore, two promigratory genes (CFL2 and NRP1) induced by TCDD was reversed by blockade of AhR. In conclusion, AhR-mediated mRNA-miR networks in the axon guidance pathway may represent a potential molecular mechanism of dioxin-induced directional migration of human neuroblastoma cells.

Emodin inhibits U87 glioblastoma cells migration by activating aryl hydrocarbon receptor (AhR) signaling pathway

Aryl hydrocarbon receptor (AhR) is a ligand-activated receptor to mediates the biological reactions of many environmental and natural compounds, which is highly expressed in glioblastoma. Although it has been reported that AhR agonist emodin can suppress some kinds of tumors, its inhibitory effect on glioblastoma migration and its relationship with AhR remain unclear. Based on the complexity of tumor pathogenesis and the tissue specificity of AhR, we hope can further understand the effect of emodin on glioblastoma and explore its mechanism. We found that the inhibitory effect of emodin on the migration of U87 glioblastoma cells increased with time, and the cell migration ability was inhibited by about 25% after 36 h exposure. In this process, emodin promoted the expression of the tumor suppressor IL24 by activating the AhR signaling pathway. Reducing the expression of AhR or IL24 by interfering RNA could block or relieve the inhibitory effect of emodin on the U87 cells migration, which indicates the inhibition of emodin on the migration of glioblastoma is mediated by the AhR-IL24 axis. Our data proved the AhR-IL24 signal axis is an important pathway for emodin to inhibit the migration of glioblastoma, and the AhR signaling pathway can be used as a key target to research the regulation effect and its mechanism of compounds on glioblastoma migration.

Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases

For decades, activation of Aryl Hydrocarbon Receptor (AhR) was excluded from consideration as a therapeutic approach due to the potential toxic effects of AhR ligands and the induction of the cytochrome P450 enzyme, Cyp1a1, following AhR activation. However, it is now understood that AhR activation not only serves as an environmental sensor that regulates the effects of environmental toxins, but also as a key immunomodulator where ligands induce a variety of cellular and epigenetic mechanisms to attenuate inflammation. Thus, the emergence of further in-depth research into diverse groups of compounds capable of activating this receptor has prompted reconsideration of its use therapeutically. The aim of this review is to summarize the body of research surrounding AhR and its role in regulating inflammation. Specifically, evidence supporting the potential of targeting this receptor to modulate the immune response in inflammatory and autoimmune diseases will be highlighted. Additionally, the opportunities and challenges of developing AhR-based therapies to suppress inflammation will be discussed.

A new insight into the role of aryl hydrocarbon receptor (AhR) in the migration of glioblastoma by AhR-IL24 axis regulation

Cancer occurrence and development are closely related to the environment. Aryl hydrocarbon receptor (AhR) is an important receptor mediating the toxic effects of many environmental compounds, and is also involved in regulating tumor cell migration. Glioblastoma is the most malignant glioma and exhibits high motility, but the effects of AhR on the migration of glioblastoma are still unclear. We aimed to understand the role of AhR in the migration of this type of tumor cell and to explore the underlying molecular mechanism. In cultured human neuroblastoma cells (U87), we found that AhR overexpression or knockdown increased or suppressed the migration ability of U87 cells, respectively. Furthermore, inhibition of basal activation of the AhR pathway suppressed migration ability, suggesting a positive correlation between endogenous activity of the AhR pathway and cell migration. When the AhR pathway was activated by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or 6-formyl [3,2-b] carbazole (FICZ), the migration of U87 cells was inhibited by inducing the expression of a tumor suppressor, IL24, which is a downstream responsive gene of AhR activation. Moreover, a similar AhR-IL24-dependent mechanism for migration inhibition of TCDD was documented in a breast cancer cell line and a lung cancer cell line. This study demonstrated that AhR plays important roles in regulating the migration of glioblastoma, and the induction of the AhR-IL24 axis mediates the inhibition of migration in response to TCDD or FICZ treatment.

Emerging therapeutic targets for neuroblastoma

INTRODUCTION

Neuroblastoma (NB) is the prime cancer of infancy, and accounts for 9% of pediatric cancer deaths. While children diagnosed with clinically stable NB experience a complete cure, those with high-risk disease (HR-NB) do not recover, despite intensive therapeutic strategies. Development of novel and effective targeted therapies is needed to counter disease progression, and to benefit long-term survival of children with HR-NB.

AREAS COVERED

Recent studies (2017-2020) pertinent to NB evolution are selectively reviewed to recognize novel and effective therapeutic targets. The prospective and promising therapeutic targets/strategies for HR-NB are categorized into (a) targeting oncogene-like and/or reinforcing tumor suppressor (TS)-like lncRNAs; (b) targeting oncogene-like microRNAs (miRs) and/or mimicking TS-miRs; (c) targets for immunotherapy; (d) targeting epithelial-to-mesenchymal transition and cancer stem cells; (e) novel and beneficial combination approaches; and (f) repurposing drugs and other strategies in development.

EXPERT OPINION

It is highly unlikely that agents targeting a single candidate or signaling will be beneficial for an HR-NB cure. We must develop efficient drug deliverables for functional targets, which could be integrated and advance clinical therapy. Fittingly, the looming evidence indicated an aggressive evolution of promising novel and integrative targets, development of efficient drugs, and improvised strategies for HR-NB treatment.